Zomedica Pharmaceuticals (ZOM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Zomedica Pharmaceuticals has appointed Scott A. Jordan as Executive Vice President, Finance and Chief Financial Officer, starting January 1, 2025. With over 30 years of experience in the life sciences and diagnostics industries, Jordan’s strategic finance and business development skills are expected to drive Zomedica’s growth in the animal health sector. His extensive background includes founding S. Jordan Associates and holding key financial roles in biotechnology companies.
For further insights into ZOM stock, check out TipRanks’ Stock Analysis page.
